» Articles » PMID: 24924602

Prevalence of Musculoskeletal Disorders and Rheumatic Diseases in an Urban Community in Monagas State, Venezuela: a COPCORD Study

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2014 Jun 14
PMID 24924602
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to determine the prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Venezuela. We conducted a cross-sectional, community-based study using the COPCORD (Community Oriented Program for Control of Rheumatic Diseases) methodology in subjects older than 18 years. Positive cases were evaluated by rheumatologists. We surveyed 3,973 individuals (1,606 males and 2,367 females), with a mean age of 43.7 years (standard deviation (SD) 17.6). Mean duration of education was 8.9 years (SD 3.7), 79.2 % had a monthly income of < US$569, and 46.4 % were working. Excluding trauma, the prevalence of pain in the 7 days prior to interview was 19.9 % (95 % confidence interval (CI) 18.7-21.2 %). Mean pain intensity on a visual analog scale was 6.3 (SD 2.2), and 30.1 % (95 % CI 28.7-31.6 %) had a history of pain. Respondents reported pain in the knees, back, hands, shoulders, and ankles in the last 7 days; 4.7 % described current functional limitation, with 16.5 % reporting limitations in the past. Regarding treatment, 23.9 % received medication, 6.4 % received physical therapy, and 2.6 % received alternative treatment. The main diagnoses were osteoarthritis in 15.0 % (95 % CI 13.9-16.1 %), rheumatic regional pain syndromes in 6.3 % (95 % CI 5.5-7.1 %), back pain in 2.8 % (95 % CI 2.3-3.4 %), rheumatoid arthritis in 0.4 % (95 % CI 0.2-0.6 %), crystal arthropathy in 0.3 % (95 % CI 0.1-0.5 %), fibromyalgia in 0.2 % (95 % CI 0.1-0.4 %), and systemic lupus erythematosus in 0.07 % (95 % CI 0.01-0.2 %). The prevalence of musculoskeletal disorders was 22.4 %, and the most prevalent disease was osteoarthritis. Pain, in which a patient is receiving treatment for musculoskeletal disorders, and physical disability were associated with the presence of a rheumatic disease.

Citing Articles

Esculin-loaded nanoparticles ameliorate adjuvant-induced polyarthritis via subduing inflammatory and oxidative stress biomarkers in Wistar rats.

Fatima M, Saleem A, Akhtar M, Akhtar K, Khan M Inflammopharmacology. 2024; 33(1):291-309.

PMID: 39731701 DOI: 10.1007/s10787-024-01621-w.


Phytochemical screening, antioxidant, immunomodulatory and analgesic potential of aqueous-ethanolic extracts of ait. and Buch-Ham.

Aslam M, Asif H, Alamri A, Bhutto A, Mukhtiar M, Ahmad K Heliyon. 2024; 10(6):e27279.

PMID: 38545175 PMC: 10965469. DOI: 10.1016/j.heliyon.2024.e27279.


Insight into the Epidemiology of the Adult-onset Systemic Autoimmune Rheumatic Diseases in Egypt: A Descriptive Study of 8690 Patients.

Attia D, Mohamed E, Ismaeel A, Suliman Y, Moneim N, Abdel Noor R Curr Rheumatol Rev. 2024; 20(5):522-533.

PMID: 38314595 DOI: 10.2174/0115733971277833231226071516.


Nationwide-incidence and trends of fibromyalgia in South Korea: a population-based study.

Lee J, Park S, Kim W, Cho H Rheumatol Int. 2023; 43(11):2049-2056.

PMID: 37624398 DOI: 10.1007/s00296-023-05410-6.


Chrysin, a 5,7-dihydroxyflavone restrains inflammatory arthritis in rats via subsiding oxidative stress biomarkers and inflammatory cytokines.

Afnan A, Saleem A, Akhtar M Inflammopharmacology. 2023; 31(4):1863-1878.

PMID: 37083920 DOI: 10.1007/s10787-023-01229-6.


References
1.
Woolf A, Brooks P, Akesson K, Mody G . Prevention of musculoskeletal conditions in the developing world. Best Pract Res Clin Rheumatol. 2008; 22(4):759-72. DOI: 10.1016/j.berh.2008.07.003. View

2.
Senna E, De Barros A, Silva E, Costa I, Pereira L, Ciconelli R . Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004; 31(3):594-7. View

3.
Chopra A . The WHO ILAR COPCORD Latin America: consistent with the world and setting a new perspective. J Clin Rheumatol. 2012; 18(4):167-9. DOI: 10.1097/RHU.0b013e31825d929b. View

4.
Arias M, Domingues E, Lozano R, Flores C, Peralta M, Salinas C . Study of class I and II HLA alleles in 30 ecuadorian patients with rheumatoid arthritis compared with alleles from healthy and affected subjects with other rheumatic diseases. Rev Bras Reumatol. 2010; 50(4):423-33. View

5.
Cardiel M, Rojas-Serrano J . Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol. 2002; 20(5):617-24. View